Products
2660 products
Code | Description | Unit |
---|---|---|
EPY0001146 | Cimetidine for system suitability | EP unit |
EPY0001147 | Orbifloxacin impurity mixture | EP unit |
EPY0001148 | Budesonide for system suitability | EP unit |
EPY0001149 | Berberine chloride | EP unit |
EPY0001151 | Hydrastine hyrochloride | EP unit |
EPY0001153 | Immunoglobulin for anti-A, anti-B antibodies limit test | EP unit |
EPY0001154 | Aprotinin for system suitability | EP unit |
EPY0001155 | Docetaxel for system suitability | EP unit |
EPY0001156 | Irbesartan impurity A - 1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide | EP unit |
EPY0001157 | Macrogol polyvinyl alcohol grafted polymer | EP unit |
EPY0001158 | Melphalan hydrochloride | EP unit |
EPY0001160 | Enrofloxacin for system suitability | EP unit |
EPY0001161 | Carbasalate impurity B - 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid) | EP unit |
EPY0001162 | Misoprostol for system suitability | EP unit |
EPY0001163 | Ursodeoxycholic acid for system suitability | EP unit |
EPY0001165 | Tetrandrine | EP unit |
EPY0001166 | Irbesartan | EP unit |
EPY0001167 | Phenytoin for system suitability | EP unit |
EPY0001168 | Potassium clavulanate impurity G - 4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoic acid | EP unit |
EPY0001169 | Dexamethasone acetate impurity E - 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl acetate | EP unit |
EPY0001170 | Ascorbic acid impurity D - methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate) | EP unit |
EPY0001171 | Astragaloside IV | EP unit |
EPY0001172 | Trehalose dihydrate | EP unit |
EPY0001173 | Filgrastim | EP unit |
EPY0001174 | Cefradine impurity mixture | EP unit |
EPY0001175 | Aristolochic acid for system suitability | EP unit |
EPY0001177 | Dexamethasone for system suitability | EP unit |
EPY0001179 | Tiotropium impurity mixture | EP unit |
EPY0001181 | Orphenadrine for peak identification | EP unit |
EPY0001182 | Captopril for system suitability | EP unit |
EPY0001183 | Trolamine impurity B - Diethanolamine | EP unit |
EPY0001184 | Trolamine impurity A - Ethanolamine | EP unit |
EPY0001185 | Aristolochic acid I | EP unit |
EPY0001186 | Salbutamol impurity J - 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (salbutamone) | EP unit |
EPY0001187 | Pramipexole for system suitability | EP unit |
EPY0001188 | Tiotropium bromide monohydrate | EP unit |
EPY0001189 | Tiotropium for system suitability | EP unit |
EPY0001190 | Galantamine natural for system suitability | EP unit |
EPY0001191 | Galantamine synthetic for system suitability | EP unit |
EPY0001192 | Hepatitis A Vaccine (Inactivated, Non-Adsorbed) | EP unit |
EPY0001193 | Clazuril | EP unit |
EPY0001194 | Resveratrol | EP unit |
EPY0001197 | Cetirizine for peak identification | EP unit |
EPY0001198 | Varicella vaccine (live) | EP unit |
EPY0001200 | Kudzuvine root dry extract | EP unit |
EPY0001201 | Galantamine racemic mixture | EP unit |
EPY0001203 | Hesperidin | EP unit |
EPY0001204 | Oleanolic acid | EP unit |
EPY0001205 | Imperatorin | EP unit |
EPY0001207 | Osthole | EP unit |
EPY0001208 | Sinomenine | EP unit |
EPY0001209 | Meglumine | EP unit |
EPY0001210 | Tobramycin for identification | EP unit |
EPY0001211 | Enalapril impurity mixture | EP unit |
EPY0001212 | Fosinopril impurity mixture | EP unit |
EPY0001213 | Foscarnet impurity mixture | EP unit |
EPY0001214 | Carmellose | EP unit |
EPY0001215 | Nadolol impurity mixture | EP unit |
EPY0001216 | Tiotropium impurity F - dithiophen-2-ylmethanone | EP unit |
EPY0001217 | Piperine | EP unit |
EPY0001218 | Isotretinoin for peak identification | EP unit |
EPY0001219 | Captopril impurity B - (2S) 1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001220 | Captopril impurity C - (2RS)-2-methyl-3-sulphanylpropanoic acid | EP unit |
EPY0001221 | Captopril impurity D - (2RS)-3-bromo-2-methylpropanoic acid | EP unit |
EPY0001222 | Foscarnet impurity D - Ethyl (diethoxyphosphinyl)formate | EP unit |
EPY0001223 | Cyproterone impurity mixture | EP unit |
EPY0001224 | Xylazine impurity mixture | EP unit |
EPY0001225 | Valaciclovir for system suitability | EP unit |
EPY0001226 | Pyridoxine impurity A - 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | EP unit |
EPY0001227 | Fosinopril sodium | EP unit |
EPY0001228 | Fosinopril impurity A - (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl] acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001229 | Fosinopril impurity B - (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001230 | Fosinopril impurity C - mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001231 | Fosinopril impurity D - (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl- 1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | EP unit |
EPY0001232 | Fosinopril impurity I - [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl) phosphoryl]acetic acid | EP unit |
EPY0001233 | Fosinopril impurity K - (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl) pyrrolidine-2-carboxylic acid | EP unit |
EPY0001234 | Lisinopril impurity F - (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine- 2-carboxylic acid (cyclohexyl analogue) | EP unit |
EPY0001236 | Econazole | EP unit |
EPY0001237 | Nimesulide for peak identification | EP unit |
EPY0001238 | Sulfinpyrazone for system suitability | EP unit |
EPY0001239 | Dobutamine impurity mixture | EP unit |
EPY0001240 | Azathioprine impurity A - 1-methyl-4-nitro-1H-imidazol-5-amine | EP unit |
EPY0001241 | Ziprasidone for system suitability 2 | EP unit |
EPY0001242 | Folic acid impurity A - (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-l-glutamic acid) | EP unit |
EPY0001243 | Folic acid impurity D - 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid) | EP unit |
EPY0001244 | Amylmetacresol | EP unit |
EPY0001245 | Amylmetacresol for peak identification | EP unit |
EPY0001246 | Azathioprine impurity G - 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine) | EP unit |
EPY0001247 | Tropicamide impurity C - (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid) | EP unit |
EPY0001249 | Entacapone | EP unit |
EPY0001250 | Entacapone impurity A - Z isomer of entacapone | EP unit |
EPY0001251 | Phentolamine mesilate for system suitability | EP unit |
EPY0001252 | Meropenem trihydrate | EP unit |
EPY0001253 | Levetiracetam | EP unit |
EPY0001254 | Levetiracetam impurity A - (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid | EP unit |
EPY0001255 | Levetiracetam impurity B - (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide | EP unit |
EPY0001256 | Levetiracetam impurity C - pyridin-2-ol | EP unit |
EPY0001257 | Levetiracetam impurity D - (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) | EP unit |
EPY0001259 | Enrofloxacin | EP unit |
EPY0001260 | Trimebutine for system suitability | EP unit |